microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer

Oncology Letters

Volumn 4, Issue 6, 2012, Pages 1290-1296

  Qin, Xiaoyan ^a   Yan, Lei ^a   Zhao, Xingbo ^a   Li, Chunyan ^a   Fu, Yibing ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Endometrioid endometrial cancer; miR 21; Proliferation; PTEN

Indexed keywords

LUCIFERASE; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER TISSUE; CELL LINE; CELL PROLIFERATION; CHROMOSOME 10; CLINICAL EVALUATION; CORRELATIONAL STUDY; DOWN REGULATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; LOSS OF FUNCTION MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

EID: 84867261213     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.896     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E and Xu J: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Tashiro H, Blazes MS, Wu R, et al: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997
3. Perren A, Weng LP, Boag AH, et al: Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 155: 1253-1260, 1999.
4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4: 199-227, 2009.
6. Meng F, Henson R, Lang M, et al: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129, 2006.
7. Meng F, Henson R, Wehbe-Janek H, et al: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007.
8. Asangani IA, Rasheed SA, Nikolova DA, et al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
9. Frankel LB, Christoffersen NR, Jacobsen A, et al: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033, 2008.
10. Zhu S, Wu H, Wu F, et al: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008.
11. Yao Q, Xu H, Zhang QQ, et al: MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun 388: 539-542, 2009.
12. Si Ml, Zhu S, Wu H, et al: miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
13. Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336, 2007.
14. Qin W, Zhao B, Shi Y, et al: BMPRII is a direct target of miR-21. Acta Biochim Biophys Sin (Shanghai) 41: 618-623, 2009.
15. Sayed D, Rane S, Lypowy J, et al: MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19: 3272-3282, 2008.
16. Torres A, Torres K, Paszkowski T, et al: Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report. Int J Gynecol Cancer 21: 8-14, 2011.
17. Snowdon J, Zhang X, Childs T, et al: The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One 6: e22828, 2011.
18. Ramon LA, Braza-Boils A, Gilabert-Estelles J, et al: microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod 26: 1082-1090, 2011.
19. Pan Q, Luo X and Chegini N: microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod 16: 215-227, 2010.
20. Cohn DE, Fabbri M, Valeri N, et al: Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol 202: 656 e1-8, 2010.
21. Lee EJ, Gusev Y, Jiang J, et al: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007.
22. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006.
23. Ma WJ, Lv GD, Tuersun A, et al: Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol Biol Rep 38: 3253-3260, 2011
24. Vogt PK, Gymnopoulos M and Hart JR: PI 3-kinase and cancer: changing accents. Curr Opin Genet Dev 19: 12-17, 2009.
25. Seo KH, Lee HS, Jung B, et al: Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res 64: 6482-6488, 2004.